| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 2,916,000 | 2,237,000 | 1,658,000 | 1,577,000 | | Cost of Revenue | 1,893,000 | 1,242,000 | 766,000 | 786,000 | | | Gross Profit | 1,023,000 | 995,000 | 892,000 | 791,000 | | | Operating Expenses | | Research Development | 12,000 | 9,000 | 13,000 | 17,000 | | Selling General and Administrative | 182,000 | 119,000 | 95,000 | 86,000 | | Non Recurring | 6,000 | 35,000 |
-
|
-
| | Others | 212,000 | 213,000 | 169,000 | 171,000 | | | | Total Operating Expenses | 412,000 | 376,000 |
-
|
-
| | | | Operating Income or Loss | 611,000 | 619,000 | 615,000 | 517,000 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 5,000 | 117,000 | (3,000) | 3,000 | | Earnings Before Interest And Taxes | 622,000 | 741,000 | 634,000 | 544,000 | | Interest Expense | 178,000 | 159,000 | 138,000 | 139,000 | | Income Before Tax | 444,000 | 582,000 | 496,000 | 405,000 | | Income Tax Expense | 166,000 | 150,000 | 298,000 | 182,000 | | Minority Interest |
-
| 1,000 |
-
|
-
| | | | Net Income From Continuing Ops | 277,000 | 433,000 | 198,000 | 223,000 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 278,000 | 433,000 | 198,000 | 223,000 | | Preferred Stock And Other Adjustments | (6,000) | (7,000) | (14,000) | (14,000) | | | Net Income Applicable To Common Shares | $272,000 | $426,000 | $184,000 | $209,000 |
|
0.29% Nasdaq 
Income Statement
